Is Gold ($1,330) About to Cross the Magic Five Year High of $1,400?
Quite literally fireworks could start once Gold Crosses $1,400. Look at these following charts and then decide for yourself.
Interview with Former UBS Managing Director and Now COO of StHealth Capital David Lessen.
While
not widely known, Wall Street’s Institutional Investment Managers and Registered
Investment Advisors (RIA’s) love using BDC
Investment Funds for their clients – to the...
Gold 2019, Here Comes the Smart Money! George Soros in the House!
That's it. Can the bell ring any louder? The Fat Lady has sung and we're starting a Gold Newsletter just as...
Innovus (INNV) Hits the Trifecta. Stuffy Noses, Hair Loss & Heartburn.
Innovative Innovus now has Three Shots on Goal with non-prescription drugs which have come off patent including a new competitor to...
Owl Rock Capital Corp. II Files for Best-Efforts IPO (S&P Global)
Owl Rock Capital Corp II has filed a Form N-2 for an initial public offering of up to 150 million of its...
HCN to Showcase how Hotels can Save up to $50 per room per month.
HCN Bringing Industry Firsts to HITEC Minneapolis via Navigator Tablet. Visit HCN in Booth 1210
Ottawa,...
Ecuador: The Largest Gold Rush in History? Initiating Coverage on Lucky Minerals (LKMNF).
Bonafide Gold Rush in Ecuador as the World’s Biggest Miners Race to Stake Claims in the Largest Land Grab in Gold...
Orchestra BioMed™ Announces Global Strategic Partnership with Terumo Corporation.
Orchestra BioMed™ Announces Global Strategic Partnership with Terumo Corporation for Development and Commercialization of Virtue® Sirolimus-Eluting Balloon.
June 13,...
Baltimore’s $10 Million Problem is Just the Tip of the Iceberg.
Some countries smartest and most ruthless computer engineers are faced with a career choice, join the Black hat hacking Company which had...
Biotech Stock Review Adds NanoVibronix (NAOV) $2.95, to Watch List.
NanoVibronix Announces Closing of $3.2 Million Private Placement to Existing Shareholders.
Adding to Watch List @ $2.95*...
Latest article
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
GeoVax (GOVX) Launches Vaccine Manufacturing System.
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System
Manufacturing Process for Phase 3 and Commercial Production...
Experts From Harvard, Scripps Research Institute, the University Hospital Zürich, and the Former Chief...
Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody...
